ImageneBio (IMA) Current Leases (2020 - 2025)
ImageneBio (IMA) posted Current Leases of $2.3 million for Q4 2025, up 4.67% sequentially from $2.2 million in Q3 2025, and up 632.04% YoY from $309000.0 in Q4 2024.
ImageneBio (IMA) Current Leases (2020 - 2025) Analysis & Trends
ImageneBio has reported Current Leases for 6 years, with the latest figure at $2.3 million in Q4 2025.
- Quarterly Current Leases rose 632.04% year-over-year to $2.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.3 million (up 632.04% YoY) and the FY2025 annual result came in at $2.3 million, up 632.04% from the prior year.
- Current Leases climbed to $2.3 million in Q4 2025 per IMA's latest filing, from $2.2 million in the prior quarter.
- Over five years, Current Leases peaked at $3.9 million in Q3 2024 and troughed at $309000.0 in Q4 2024.
- A 5-year average of $2.5 million and a median of $1.9 million in 2023 frame the typical range for Current Leases.
- The sharpest annual moves came in 2021 and 2024: Current Leases soared 895.16% in 2021, then tumbled 91.32% in 2024.
- Over 5 years, Current Leases stood at $1.9 million in 2021, then rose by 3.03% to $1.9 million in 2022, then soared by 86.58% to $3.6 million in 2023, then sank by 91.32% to $309000.0 in 2024, then surged by 632.04% to $2.3 million in 2025.
- According to Business Quant data, Current Leases over the past three periods registered $2.3 million, $2.2 million, and $3.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | ImageneBio | 48.60 Mn | -86.75 Mn | - | 2.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.26 Mn |
| Sep 30, 2025 | 2.16 Mn |
| Jun 30, 2025 | 3.83 Mn |
| Mar 31, 2025 | 3.89 Mn |
| Dec 31, 2024 | 309,000.00 |
| Sep 30, 2024 | 3.92 Mn |
| Jun 30, 2024 | 3.70 Mn |
| Mar 31, 2024 | 3.44 Mn |
| Dec 31, 2023 | 3.56 Mn |
| Sep 30, 2023 | 3.47 Mn |
| Jun 30, 2023 | 1.94 Mn |
| Mar 31, 2023 | 1.92 Mn |
| Dec 31, 2022 | 1.91 Mn |
| Sep 30, 2022 | 1.89 Mn |
| Jun 30, 2022 | 1.88 Mn |
| Mar 31, 2022 | 1.86 Mn |
| Dec 31, 2021 | 1.85 Mn |
| Sep 30, 2021 | 1.84 Mn |
| Jun 30, 2021 | 1.83 Mn |
| Mar 31, 2021 | 1.58 Mn |